INSULET CORP (NASDAQ:PODD) was identified by our screener as a strong growth stock with a favorable technical setup. The company, known for its innovative insulin delivery systems, combines solid fundamental growth metrics with a promising chart pattern. Below, we examine why PODD stands out.
Strong Growth Fundamentals
Revenue & Earnings Growth: PODD has delivered impressive revenue growth of 23.49% over the past year, with earnings per share (EPS) increasing by 12.11%. Long-term EPS growth averages 79.24% annually.
Profitability: The company earns a high profitability rating of 9/10, with strong margins—18.29% profit margin and 70.39% gross margin, outperforming most peers.
Valuation: While the P/E ratio is elevated at 85.23, it remains cheaper than 65% of industry competitors. Analysts expect continued earnings growth of 21.65% annually, which may justify the premium.
Technical Setup
Trend & Momentum: The long-term trend remains positive, with the stock trading near the upper end of its 52-week range. A recent pocket pivot signal suggests accumulation.
Support Levels: Key support lies between $296.44 and $303.85, providing a potential stop-loss zone for traders.
Consolidation Breakout: PODD has been consolidating in a range between $295.56 and $329.10. A breakout above resistance near $325 could signal further upside.
This is not investing advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.